Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents)
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SMITHKLINE BECKMAN CORP
- Publication Date
- 2004-03-31
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
[0001] This invention relates to a novel tetrahydrobenzazepine derivative, its preparation process, intermediates used in the process, pharmaceutical compositions containing this substance, and as dopamine D 3 Receptor modulators, especially for therapeutic use as neuroleptics. Background of the invention
[0002] U.S. Patent No. 5,294,621 describes derivatives of tetrahydropyridine of the formula:
[0003]
[0004] in
[0005]
[0006] is an optionally substituted thienyl or an optionally substituted benzene ring; R 1 , R 2 and R 3 are H atoms; X is (CH 2 ) m NR 7 CO, where m is 2-4; Ar 1 is an optionally substituted heterocycle or an optionally substituted benzene ring. The compound is said to be useful as an antiarrhythmic drug.
[0007] Patent EPA 431,580 describes certain dopaminergic agents useful as tranquillizers, antihypertensives, etc. Patent WO 95 / 10513 describes benzothiophene derivatives and related compounds, which are useful as estrogen agonists....